Integra LifeSciences (IART) Tops Q4 EPS by 5c

Integra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.94, $0.05 better than the analyst estimate of $0.89. Revenue for the quarter came in at $252.2 million versus the consensus estimate of $244.39 million.

Integra LifeSciences sees FY2015 EPS of $3.05-$3.23, versus the consensus of $3.27. Integra LifeSciences sees FY2015 revenue of $960-980 million, versus the consensus of $976.8 million.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• KeyBanc Downgrades Kite Realty Group (KRG) to Sector Weight
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy